From eye drops to potential leukaemia treatment

by Wellcome Trust Sanger InstituteA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaAn active ingredient

Updated on: March 12,2024

From eye drops to potential leukaemia treatment

by Wellcome Trust Sanger InstituteA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaAn active ingredient

Updated on:March 12,2024

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o

Updated on: February 18,2024

'Dead zone' within tumor promotes cancer spread, helped by a protein secreted by cancer cells

by Diana Mapes, Fred Hutchinson Cancer CenterFred Hutch's Ami Yamamoto, foreground, at work in the lab of Dr. Kevin Cheung (seen in background). Yamamoto's investigation of the necrotic core o

Updated on:February 18,2024

Ethical issues abound in adoption of AI in cancer care

by Lori SolomonThere may be ethical barriers to the adoption of artificial intelligence (AI) into cancer care, according to a studypublishedonline March 28 inJAMA Network Open.Andrew

Updated on: April 06,2024

Ethical issues abound in adoption of AI in cancer care

by Lori SolomonThere may be ethical barriers to the adoption of artificial intelligence (AI) into cancer care, according to a studypublishedonline March 28 inJAMA Network Open.Andrew

Updated on:April 06,2024

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on: January 22,2024

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on:January 22,2024

Exploring CAR T-cell therapy for aggressive follicular lymphoma

by Olivia Dimmer,Northwestern UniversityORR by best overall response per IRC assessment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02986-9CAR T-cell therapy is an effecti

Updated on: August 01,2024

Exploring CAR T-cell therapy for aggressive follicular lymphoma

by Olivia Dimmer,Northwestern UniversityORR by best overall response per IRC assessment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02986-9CAR T-cell therapy is an effecti

Updated on:August 01,2024

Engineered T cells may be harnessed to kill solid tumor cells

by Tel Aviv UniversityCredit: Tel Aviv UniversityThere is now a multitude of therapies to treat cancer, from chemotherapy and radiation to immunotherapy and small molecule inhibitors. Chemotherap

Updated on: March 01,2024

Engineered T cells may be harnessed to kill solid tumor cells

by Tel Aviv UniversityCredit: Tel Aviv UniversityThere is now a multitude of therapies to treat cancer, from chemotherapy and radiation to immunotherapy and small molecule inhibitors. Chemotherap

Updated on:March 01,2024

Discovery suggests which thyroid cancer patients may need more aggressive treatment

by Ross Neitz,University of AlbertaOncology professor and surgeon Todd McMullen (right) says the study will help surgeons determine which patients will benefit from less aggressive treatment and

Updated on: April 18,2024

Discovery suggests which thyroid cancer patients may need more aggressive treatment

by Ross Neitz,University of AlbertaOncology professor and surgeon Todd McMullen (right) says the study will help surgeons determine which patients will benefit from less aggressive treatment and

Updated on:April 18,2024

Editorial: GBP3-STING interaction in glioblastoma coordinates poor response to temozolomide

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncotarget, titled "GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative

Updated on: March 06,2024

Editorial: GBP3-STING interaction in glioblastoma coordinates poor response to temozolomide

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncotarget, titled "GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative

Updated on:March 06,2024

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on: March 21,2024

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on:March 21,2024

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on: January 30,2024

Drug combo ups progression-free survival for metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), accord

Updated on:January 30,2024

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Updated on: July 04,2024

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Updated on:July 04,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on: March 30,2024

Predicting immunotherapy response and guiding combination therapy with MOTIF

byScience China PressWorkflow of MOTIF and three main application including cellular function analysis, immunotherapy response prediction and combinational therapy guidance. Credit: Science Chin

Updated on:March 30,2024